/Pfizer%20Inc_%20logo%20on%20iPad-by%20Koshiro%20K%20via%20Shutterstock.jpg)
Income investors tend to gravitate towards covered calls, and blue-chip high yielding stocks are a great place to start.
Pfizer (PFE) has been a strong performer in 2026 and is up 9.64% so far this year.
/Pfizer%20Inc_%20logo%20on%20iPad-by%20Koshiro%20K%20via%20Shutterstock.jpg)
Income investors tend to gravitate towards covered calls, and blue-chip high yielding stocks are a great place to start.
Pfizer (PFE) has been a strong performer in 2026 and is up 9.64% so far this year.